Oral Lactobacillus paracasei improves skin barrier function recovery and reduces local skin inflammation

European Journal of Dermatology

Volumn 21, Issue 2, 2011, Pages 279-280

  Philippe, David ^a   Blum, Stephanie ^a   Benyacoub, Jalil ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; PROBIOTIC AGENT; ST 11; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; EAR SWELLING; FEMALE; LACTOBACILLUS PARACASEI; LETTER; MOUSE; NONHUMAN; SKIN BARRIER FUNCTION; SKIN FUNCTION; SKIN INFLAMMATION; SKIN WATER LOSS; SWELLING;

ANIMALS; DINITROCHLOROBENZENE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFLAMMATION; IRRITANTS; LACTOBACILLUS; MICE; MICE, INBRED STRAINS; PROBIOTICS; SKIN;

EID: 79960798818     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1242     Document Type: Letter

References (6)

1. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2010, [Epub ahead of print].
2. Von der Weid T, Bulliard C, Schiffrin EJ. Induction by a lactic acid bacterium of population of CD4+ T cells with low proliferative capacity that produces transforming growth factor α and interleukin 10. Clin Diag Lab Immunol 2001; 8: 695-701.
3. Ibnou-zekri N, Blum S, Schiffrin EJ, Von der Weid T. Divergent patterns of colonisation and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 2003; 71: 428-36.
4. Gueniche A, Benyacoub J, Philippe D, et al. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatol 2010; 20: 731-7.
5. Han MH, Yoon WK, Lee H, et al. Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c mice. Int Immunopharmacol 2007; 7: 1651-8.
6. Gueniche A, Buetler B, Benyacoub J, Blum S. Lactobacillus johnsonii provides a dose-dependent protection against UVR-induced immunosuppression. Eur J Dermatol 2008; 18: 476-7.